Global Multicentre Kidney Transplant Advagraf Conversion Registry. A Non-interventional Post-authorisation Study (PAS)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 29 Nov 2017
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms CHORUS
- Sponsors Astellas Pharma Europe Ltd
- 23 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 22 May 2017 Planned number of patients changed from 6000 to 4500.
- 25 Sep 2015 New trial record